Patent classifications
C07C327/30
METHOD FOR FUNCTIONALIZING CARBON NANOPARTICLES AND COMPOSITIONS
A method of increasing a density of carboxylic acids on a surface of a carbon nanoparticle is disclosed. The method includes contacting an oxygen-containing functional group on a surface of a carbon nanoparticle with a reducing agent to provide a hydroxyl group; reacting the hydroxyl group with a diazoacetate ester in the presence of a transition metal catalyst to provide an ester, the diazoacetate ester having the structure wherein R is a C1-8 hydrocarbyl, preferably tert-butyl, methyl, ethyl, isopropyl, allyl, benzyl, pentafluorophenyl, or N-succinimidyl; and cleaving the ester to provide a carboxylic acid group. Surface-functionalized carbon nanoparticles made by the method are also disclosed.
Process for preparing aminothiol ester compounds and salts thereof
A process for preparing aminothiol ester compounds and salts thereof. The present invention relates to a process for preparing compounds of formula (I), (I) comprising the following steps: a) reacting a compound of formula (II) with an inorganic acid or an organic acid, (II) b) reacting the compound obtained in step a) with a base; c) reacting the compound obtained in step b) with CO.sub.2; d) reacting the compound obtained in step c) with an alkyl chloroformate, a reagent capable of forming, with the compound obtained in step c), an acid halide, or a reagent capable of forming, with the compound obtained in step c), a mixed anhydride; e) reacting the compound obtained in step d) with an SMe anion precursor compound. ##STR00001##
Process for preparing aminothiol ester compounds and salts thereof
A process for preparing aminothiol ester compounds and salts thereof. The present invention relates to a process for preparing compounds of formula (I), (I) comprising the following steps: a) reacting a compound of formula (II) with an inorganic acid or an organic acid, (II) b) reacting the compound obtained in step a) with a base; c) reacting the compound obtained in step b) with CO.sub.2; d) reacting the compound obtained in step c) with an alkyl chloroformate, a reagent capable of forming, with the compound obtained in step c), an acid halide, or a reagent capable of forming, with the compound obtained in step c), a mixed anhydride; e) reacting the compound obtained in step d) with an SMe anion precursor compound. ##STR00001##
MALONYL-COENZYME A MIMICS AS FATTY ACID SYNTHASE INHIBITORS AND METHODS OF USE
The present disclosure generally relates to novel compounds as a fatty acid synthase inhibitor useful for the treatment of infection diseases, cancers, or metabolic diseases that malfunction of fatty acid synthase is involved. In particular this present invention directs to malonyl-coenzyme A (CoA) mimetics and methods of use thereof. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases in mammals using compounds disclosed herein.
Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
The cationic lipid compound and composition for delivering nucleic acids as shown in formula (I) and their use are disclosed. The use of nano lipid particles with the compound as a key component in nucleic acid delivery is also disclosed, including the composition, preparation method, and usage method of the delivery carrier.
##STR00001##
Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
The cationic lipid compound and composition for delivering nucleic acids as shown in formula (I) and their use are disclosed. The use of nano lipid particles with the compound as a key component in nucleic acid delivery is also disclosed, including the composition, preparation method, and usage method of the delivery carrier.
##STR00001##
Cyclic pantetheine derivatives and uses thereof
The present disclosure relates to compounds of Formula (P) or (II-0): (Formulae (I), (II-0)), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions. ##STR00001##
Process for the preparation of a sulfur-amine
The present invention relates to a process for the synthesis of cysteamine or a salt thereof.
Process for the preparation of a sulfur-amine
The present invention relates to a process for the synthesis of cysteamine or a salt thereof.
PROCESS FOR PREPARING AMINOTHIOL ESTER COMPOUNDS AND SALTS THEREOF
A process for preparing aminothiol ester compounds and salts thereof. The present invention relates to a process for preparing compounds of formula (I), (I) comprising the following steps: a) reacting a compound of formula (II) with an inorganic acid or an organic acid, (II) b) reacting the compound obtained in step a) with a base; c) reacting the compound obtained in step b) with CO.sub.2; d) reacting the compound obtained in step c) with an alkyl chloroformate, a reagent capable of forming, with the compound obtained in step c), an acid halide, or a reagent capable of forming, with the compound obtained in step c), a mixed anhydride; e) reacting the compound obtained in step d) with an SMe anion precursor compound.
##STR00001##